Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Study Of Ruxolitinib (INCB018424) With Preoperative Chemotherapy For Triple Negative Inflammatory Breast Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02876302
Recruitment Status : Active, not recruiting
First Posted : August 23, 2016
Last Update Posted : June 24, 2021
Sponsor:
Collaborator:
Incyte Corporation
Information provided by (Responsible Party):
Filipa Lynce, Dana-Farber Cancer Institute

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Active, not recruiting
Estimated Primary Completion Date : February 2022
Estimated Study Completion Date : February 2024